Agendia N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
20 jun 2011 - 20:02
Statutaire naam
Agendia N.V.
Titel
Agendia postpones its IPO due to unfavourable market conditions
Bericht
Agendia (or the “Company”), a commercial-stage molecular cancer diagnostics company, announces the postponement of its Initial Public Offering (“IPO”) that was due to price today. Agendia announced its intention to float on 20 May 2011 and started its book building process on 6 June 2011. The timetable has coincided with an extraordinarily volatile period in global capital markets resulting in high levels of uncertainty and volatility that do not meet the existing shareholders' and the Company's desire to achieve a successful IPO with an orderly aftermarket.
Datum laatste update: 23 februari 2026